EN
HI
Summary
As of 27 Aug, 2026, Concord Drugs stock price is ₹77.1. During the trading session, the stock has moved between an intraday low of ₹76.50 and an intraday high of ₹80.50. Over the last 52 weeks, Concord Drugs has traded between ₹56.17 and ₹92.52.
The stock has recorded a trading volume of 2,561 shares, with a market capitalization of ₹13175000. Its Average Traded Price (ATP) is ₹78.69, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 25 @ ₹77.10.
Concord Drugs has an upper circuit limit of ₹96.60 and a lower circuit limit of ₹64.40. The total value traded stands at ₹2.02 L, and the delivery percentage for the day is 76.3%.
The stock is currently traded with a market lot size of 1. Concord Drugs also offers a dividend yield of 0%.
Concord Drugs share price chart
Concord Drugs Share Key Metrics
Volume
2561.00
Market Cap
106.06 CR
LTQ@LTP
25@77.10
ATP
78.69
Var Margin
25 %
Circuit Range
64.4-96.6
Delivery %
76.3 %
Value
2.02 L
ASM/GSM
No
Market Lot
1
Concord Drugs Fundamentals
P/E Ratio
51.71
P/B Ratio
2.14
Div. Yield
0
Sector P/E
68.54
Sector P/B
3.38
Sec. Div. Yield
0.51
Concord Drugs Resistance and Support
Pivot 79.63
Resistance
First Resistance
82.46
Second Resistance
84.43
Third Resistance
87.26
Support
First Support
77.66
Second Support
74.83
Third Support
72.86
Concord Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Aug 27 2026 | 80.5 | 77.1 | -4.22% | 80.5 | 76.5 |
| Wed Aug 26 2026 | 81.59 | 80.5 | 1.87% | 81.59 | 76.8 |
| Tue Aug 25 2026 | 76 | 79.02 | 3.08% | 80 | 73 |
Concord Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-27 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-07-03 | Preferential issue of shares |
| 2025-06-27 | Preferential Issue of shares & Others |
| 2025-05-23 | Audited Results |
| 2025-03-17 | Preferential Issue of shares & Others |
| 2025-03-13 | Preferential Issue of shares & Others |
| 2025-01-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Drugs News
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Quarterly Results
Concord Drugs' board is scheduled to meet on August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. This meeting will finalize the company's performance for the first quarter of FY27.
Aug 03 2026 17:21:49
Concord Drugs Management
| Name | Position |
|---|---|
| S Nagi Reddy | Chairman & Managing Director |
| S Koni Reddy | Whole Time Director & Chief Financial Officer |
Concord Drugs Similar Stocks
Raaj Medisafe India Ltd.
88.16
4.19 (4.99%)
Pharmaids Pharmaceuticals Ltd.
32.37
0.99 (3.15%)
Mercury Laboratories Ltd.
800.00
20.00 (2.56%)
Bharat Immunologicals & Biologicals Corporation Ltd.
16.03
0.05 (0.31%)
Everest Organics Ltd.
299.00
3.15 (1.06%)
Godavari Drugs Ltd.
99.90
-0.10 (0.10%)
Kretto Syscon Ltd.
0.48
0.00 (0.00%)
Vasundhara Rasayans Ltd.
155.40
0.65 (0.42%)
Concord Drugs FAQs
The Buying Price of Concord Drugs share is 77.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Drugs shares is 51.71. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Drugs shares is 2.14. Useful to assess the stock's value relative to its book value.
To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 68.54 & 3.38 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Drugs is 106.06 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Drugs share price is 92.52 & 56.17. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
